Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03439267 · ClinicalTrials.gov registry record · NA
Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events
A NA study of Cardiovascular Primary Prevention Strategy, sponsored by Intermountain Health Care.
- Active
- Registry status
- NA
- Development phase
- 5,765
- Enrollment target
- 1
- Study location
NCT03439267 is a NA study of Cardiovascular Primary Prevention Strategy that is active but no longer recruiting, run by Intermountain Health Care. The registered enrollment target is 5,765 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03439267, a NA study of Cardiovascular Primary Prevention Strategy, is active but no longer recruiting, sponsored by Intermountain Health Care.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 5,765 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to test the effectiveness of a proactive cardiovascular primary prevention strategy, with or without the use of coronary calcium screening, compared to current standard care, in preventing future major adverse cardiac events (MACE), including all-cause death, non-fatal myocardial infarction (MI), stroke, or any arterial revascularization among a moderate risk population with no current evidence of cardiovascular disease.
Conditions Studied
Interventions
- OTHER Standard Treatment
- COMBINATION_PRODUCT Coronary Artery Calcium Screening and Statin Treatment
Study Locations (1)
Utah
- Intermountain Medical Center and Intermountain Clinics - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,765 participants |
| Start Date | 2018-03-26 |
| Est. Completion | 2027-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03439267
The ClinicalTrials.gov registry entry for NCT03439267 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 5,765 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiovascular Primary Prevention Strategy appearing as the primary indexed condition, and to 2 interventions - of which Standard Treatment is the first listed.
NCT03439267 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT03439267 about?
NCT03439267 is a clinical study titled "Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events". The primary objective of this study is to test the effectiveness of a proactive cardiovascular primary prevention strategy, with or without the use of coronary calcium screening, compared to current standard care, in preventing future major adverse cardiac events (MACE), including all-cause death, n...
What is the current status of trial NCT03439267?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 5,765 participants. The study started on 2018-03-26. Estimated completion is 2027-05.
What conditions does trial NCT03439267 study?
This clinical trial studies the following conditions: Cardiovascular Primary Prevention Strategy.
What interventions are being tested in trial NCT03439267?
The interventions under investigation include: Standard Treatment (OTHER), Coronary Artery Calcium Screening and Statin Treatment (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03439267?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03439267 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.